CD40LG and Guillain-Barre syndrome: Significantly more ZIKV patients with GBS had IgM antibodies against ZIKV (93%) than control group 1 patients, while ZIKV was detected in 100% of control group 2 patients, providing evidence for ZIKV as a risk factor for GBS [10].